Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Beta-1,3/1,6-D-Glucan From Mycelium Extract of Indonesian Ganoderma Lucidum on Ulcerative Colitis: A Double-Blind Randomized Controlled Trial

NCT04029649 is registered in ClinicalTrials.gov with Fakultas Kedokteran Universitas Indonesia as lead sponsor.

NCT NCT04029649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04029649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Beta-1,3/1,6-D-Glucan From Mycelium Extract of Indonesian Ganoderma Lucidum on Ulcerative Colitis: A Double-Blind Randomized Controlled Trial
Lead sponsor
Fakultas Kedokteran Universitas Indonesia
Phase
Phase 2/3
Overall status
Unknown status
Start date
August 31, 2019
Completion date
December 31, 2020
Enrollment
204 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis